BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.84B
AUM Growth
+$311M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$28M
2
+$16.1M
3
+$15.1M
4
AVXS
AveXis, Inc. Common Stock
AVXS
+$14.5M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.91M

Top Sells

1
+$120M
2
+$18M
3
+$15.7M
4
PBYI icon
Puma Biotechnology
PBYI
+$12.7M
5
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$5.88M

Sector Composition

1 Healthcare 88.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$366M 12.86%
3,879,822
+39,416
2
$362M 12.71%
3,459,298
-150,000
3
$262M 9.23%
7,163,172
+58,334
4
$236M 8.29%
4,360,399
5
$220M 7.72%
2,774,596
6
$158M 5.56%
3,121,552
7
$145M 5.08%
1,179,428
8
$140M 4.92%
2,649,528
+286,207
9
$123M 4.34%
1,415,445
10
$98.5M 3.46%
245,000
+40,000
11
$97.7M 3.43%
974,582
-180,000
12
$89.1M 3.13%
7,379,832
13
$80.7M 2.84%
1,191,338
14
$55.2M 1.94%
1,685,150
15
$49.4M 1.74%
2,041,900
16
$47.1M 1.66%
1,022,439
+171,800
17
$44.7M 1.57%
800,000
+50,000
18
$43.5M 1.53%
1,455,000
+935,000
19
$42.2M 1.48%
1,405,000
+100,000
20
$42.1M 1.48%
255,719
21
$21M 0.74%
350,000
22
$20.6M 0.72%
1,350,000
+650,000
23
$18.1M 0.64%
1,308,542
+300,000
24
$17.3M 0.61%
416,500
25
$16.6M 0.58%
1,182,912
1
2